Ann Neale has more than 18 years of clinical development experience in the pharmaceutical/biopharmaceutical industry in the United States, Canada and Europe. Ann brings both therapeutic and business experience to Synosia and expertise in strategic planning to take lead molecules into clinical development. Before joining Synosia, Ann was vice president of clinical operations at Saegis Pharmaceuticals, responsible for the strategic planning and clinical development of the company's central nervous system (CNS) compounds. She also has extensive experience in development operations for other companies including ARYx Therapeutics and Mimetix Incorporated, as well as being a principal in WinPharm Associates, a clinical drug development consulting company. Ann received her bachelor's of science in nursing degree from the University of Minnesota and is the author of a several publications and abstracts